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Abnormal X chromosome inactivation 
and sex-specific gene dysregulation 
after ablation of FBXL10
Mathieu Boulard1*, John R. Edwards2 and Timothy H. Bestor1
Abstract 
Background:  Almost all CpG-rich promoters in the mammalian genome are bound by the multidomain FBXL10 
protein (also known as KDM2B, JHDM1B, CXXC2, and NDY1). FBXL10 is expressed as two isoforms: FBXL10-1, a longer 
form that contains an N-terminal histone demethylase domain with C-terminal F-box, CXXC, PHD, RING, and leucine-
rich repeat domains, and FBXL10-2, a shorter form that initiates at an alternative internal exon and which lacks the his-
tone demethylase domain but retains all other annotated domains. Selective deletion of Fbxl10-1 had been reported 
to produce a low penetrance and variable phenotype; most of the mutant animals were essentially normal. We 
constructed mutant mouse strains that were either null for Fbxl10-2 but wild type for Fbxl10-1 or null for both Fbxl10-1 
and Fbxl10-2.
Results: Deletion of Fbxl10-2 (in a manner that does not perturb expression of Fbxl10-1) produced a phenotype 
very different from the Fbxl10-1 mutant, with craniofacial abnormalities, neural tube defects, and increased lethality, 
especially in females. Mutants that lacked both FBXL10-1 and FBXL10-2 showed embryonic lethality and even more 
extreme sexual dimorphism, with more severe gene dysregulation in mutant female embryos. X-linked genes were 
most severely dysregulated, and there was marked overexpression of Xist in mutant females although genes that 
encode factors that bind to Xist RNA were globally downregulated in mutant female as compared to male embryos.
Conclusions: FBXL10 is the first factor shown to be required both for the normal expression and function of the Xist 
gene and for normal expression of proteins that associate with Xist RNA; it is proposed that FBXL10 coordinates the 
expression of Xist RNA with proteins that associate with this RNA. The function of FBXL10 is largely independent of the 
histone demethylase activity of the long form of the protein.
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Background
FBXL10 is a multidomain chromosomal protein that is 
localized to essentially all CpG-rich promoters via a CXXC 
domain that binds to unmethylated CpG dinucleotides 
[1, 3]. FBXL10 is present in a variant form of Polycomb 
Repressive Complex 1 (PRC1), but most FBXL10 is depos-
ited at promoters that are not associated with Polycomb 
factors. Many biological functions have been ascribed 
to FBXL10; among these are the regulation of nucleolar 
function [3], organization of Polycomb Repressive Com-
plexes [3, 4], self-renewal of stem cells [5], and regulation 
of histone H2A ubiquitylation [6]. However, these studies 
were conducted prior to the demonstration that FBXL10 is 
bound to all CpG-rich promoters and none utilized mouse 
strains null for Fbxl10. FBXL10 has also been reported to 
be an oncogene and a tumor suppressor in leukemia [7, 
8]. The biological activities of FBXL10 are usually attrib-
uted to the JmjC histone demethylase domain, although 
FBXL10 also contains CXXC, PHD, RING, F-box, and leu-
cine-rich repeat (LRR) domains. It was recently reported 
that FBXL10 is required for the protection of sequences 
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bound by Polycomb Repressive Complexes from de novo 
methylation, while promoters bound by FBXL10 but not 
by Polycomb Repressive Complexes did not undergo de 
novo methylation after removal of FBXL10 [9].
Ablation of the long form of the protein (the JmjC-
containing FBXL10-1) was reported to produce a fully 
recessive phenotype in which most homozygous mice 
were of normal phenotype but some displayed colo-
boma, exencephaly, and rare tail kinks [10]. A single 
conservative amino acid substitution that affects both 
FBXL10-1 and FBXL10-2 causes paunch calf syndrome 
with craniofacial dysmorphia and perinatal lethality in 
Romagnolo cattle; this mutation is also fully recessive 
[11]. A deletion that removed the CXXC domain (which 
is common to both FBXL10-1 and FBXL10-2) was 
reported to produce increased lethality and develop-
mental abnormalities in heterozygous mice as a result of 
haploinsufficiency, but this mutant allele produced large 
amounts of an abnormal protein that could have exerted 
neomorphic effects [4]. The semidominant character 
of this allele contrasts with the fully recessive nature 
of all other mutant alleles of Fbxl10 (including alleles 
described here).
We report here that a mutant allele that deleted 
Fbxl10-2 in a manner that did not affect expression of 
Fbxl10-1 was fully recessive and produced a phenotype 
that differed markedly from the Fbxl10-1 deletion. The 
Fbxl10-2 mutation caused craniofacial abnormalities, 
with high rates of perinatal lethality and a strain-depend-
ent cleft palate and eyes-open-at-birth phenotype. We 
observed that female homozygotes had a more severe 
phenotype and that very few survived to adulthood. We 
further investigated the sexual dimorphism in embryos 
that lacked both FBXL10-1 and FBXL10-2 and found 
dysregulation of many genes in female embryos, with 
pronounced dysregulation of X-linked genes and strong 
overexpression of Xist specifically in female embryos, 
with a net decrease in X-linked gene expression that was 
not detectable in male embryos. Male embryos showed 
greatly decreased Tsix expression but did not detectably 
reactivate Xist. The data indicate that removal of FBXL10 
results in widespread dysregulation of gene expres-
sion, with much larger effects in female embryos and 
even greater dysregulation of X-linked genes. FBXL10 
is a novel factor that is required for normal expression 
of Xist and Tsix and for the coordinated expression of 




All animal experimentation was conducted under pro-
tocols approved by the Institutional Animal Care and 
Use Committee of Columbia University. The Fbxl10T/T 
null strain was described in [9], and construction of the 
Fbxl10∆−2/∆−2 strain in which Fbxl10-2 is selectively 
deleted is diagrammed in Fig.  1a and Additional file  1: 
Fig. S1. All PCR primer sequences and other information 
related to the construction of this strain are available on 
request.
RNA‑seq analysis
Two biological replicates for each genotype of both 
sexes were analyzed. Total RNA was extracted from sin-
gle embryos dissected at embryonic day E9.5. The sex of 
the embryos was determined by PCR detection of the 
Sry gene using genomic DNA extracted from the yolk 
sac. RNA-seq reads were mapped to the mouse genome 
(mm9) using TopHat (v1.4.1; [12]). Mapped reads were 
assigned to RefSeq annotated genes using htseq-count 
(version 0.5.3p9; http://www-huber.embl.de/users/
anders/HTSeq/doc/count.html). Differential expres-
sion was assessed by edgeR (http://www.ncbi.nlm.nih.
gov/pmc/articles/PMC2796818/) with TMM normali-
zation. Log2 fold-changes were computed after apply-
ing a floor of 1 cpm to ensure that genes with very low 
expression but large fold-changes did not affect the anal-
ysis. Pearson’s correlation coefficient was used to com-
pare the global variation in expression levels in +/+ and 
T/T mice. Distributions of log2 fold expression changes 
between autosomal and ChrX genes were compared 
using the Mann–Whitney U test.
GSEA analysis
Gene set enrichment analysis was performed as in [13] 
using the log2 fold-change to rank genes. A custom gene 
signature from 81 Xist interacting factors [14] was used 
for the analysis. The density of Xist bound factors was 
computed as the number of genes in a 2000 gene win-
dow normalized by the window size as the window slides 
across the ranked gene list. P values are those reported 
from GSEA for the enrichment of Xist bound factors.
ChIP‑Seq analysis
FBXL10 ChIP-Seq data from mouse ES cells are from 
GSE41316 [3].
Data access
The RNA-seq data were deposited at the Gene Expres-
sion Omnibus under the Accession number GSE76552.
Results
Selective deletion of FBXL10‑2: sexually dimorphic 
phenotype distinct from FBXL10‑1 mutation
As shown in Fig. 1a, b, FBXL10-2 differs from FBXL10-1 
by the absence of an N-terminal domain that contains a 
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JmjC histone demethylase domain. As mentioned previ-
ously, a deletion that selectively removed FBXL10-1 was 
reported to have a weakly penetrant recessive phenotype 
characterized by low-frequency exencephaly, coloboma, 
and tail kinks, although most homozygous mutants were 
without visible phenotype [10]. We selectively removed 
FBXL10-2 by introduction of loxP sites followed by Cre-
mediated excision of the alternative internal promoter 
and first exon that drive expression of FBXL10-2 (Fig. 1b, 
Additional file 1: Fig. S1). As shown in Fig. 1b, c, the dele-
tion removed all detectable FBXL10-2 protein without 
measurable effect on FBXL10-1.
The FBXL10-1 and FBXL10-2 deletions had markedly 
different phenotypes. The FBXL10-2 deletion did not 
show exencephaly, coloboma, or kinked tail as did the 
FBXL10-1 mutants. In contrast, surviving animals lack-
ing FBXL10-2 were runted and displayed craniofacial 
abnormalities (Additional file 1: Fig. S2a), while mutants 
that died prenatally showed craniofacial and neural 
tube abnormalities (Fig.  1d). When backcrossed onto 
the FVB genetic background, the Fbxl10∆−2/∆−2 muta-
tion additionally caused cleft pallet and open eyelids at 
birth (Fig. 1d, Additional file 1: Fig. S2b). We performed 
all gene expression experiments on the C57Bl6 strain 
background.
While Fbxl10-2 is expressed at the same level in males 
and females (Fig. 1c), fewer females (P = 0.000319) than 
males (P =  0.7829) survived to postnatal day 21 (Addi-
tional file 2: Table S1).
Abnormal development and gene expression 
in Fbxl10‑null embryos
Further investigation of the sexually dimorphic phe-
notype was conducted in embryos homozygous for a 
Fig. 1 a Domain organization of FBXL10-1 and FBXL10-2 proteins. b Intron–exon structure of Fbxl0-1 and Fbxl0-2 genes and Cre-mediated deletion 
of promoter and first exon of Fbxl10-2. LoxP sites introduced by homologous recombination are shown as blue arrowheads. The alternative first exon 
of Fbxl10-2 is not present in transcript of Fbxl10-1. Gene trap truncation (T allele) is a null allele of both Fbxl10-1 and Fbxl10-2 and is described in [9]. 
c Immunoblot confirmation that the deletion shown in b and denoted as Δ-2 prevents expression of FBXL10-2. The gene trap allele denoted as T 
eliminates both forms of FBXL10. d Craniofacial abnormalities in E12.5 embryos (top row) and E17.5 embryos (bottom row) homozygous for the Δ-2 
allele. Compression of the anterior portion of the head is apparent (top and bottom rows), as is the eyes-open-at-birth phenotype (black arrowhead 
at bottom). A tortuous neural tube was observed in both T/T and Δ-2/Δ-2 embryos (middle row)
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truncating gene trap allele (Fbxl10T) that removes all 
detectable FBXL10-1 and FBXL10-2 protein and is a null 
allele (Fig.  1b, c). These embryos showed a much more 
severe phenotype and more pronounced sexual dimor-
phism than Fbxl10∆−2/∆−2 mutants  (Fig.  1d), as shown 
in Fig. 2. Embryonic development ceased prior to E10.5, 
with multiple and severe developmental abnormalities, 
including neural tube kinks similar to those observed in 
Fbxl10∆−2/∆−2 mutants. Figure 2 shows the sexual dimor-
phism resulting from FBXL10-1 and FBXL10-2 ablation; 
the most advanced female embryos were observed to 
cease development at roughly the same stage at the least 
advanced male embryos.
RNA-seq was performed on RNA from stage-matched 
female (XX) and male (XY) Fbxl10T/T mutant embryos 
at E9.5; as shown in Fig.  3a, developmental abnormali-
ties were much less severe at E9.5 than in the E10.5 
embryos shown in Fig.  2. In agreement with the depo-
sition of FBXL10 at all CpG-rich promoters  [1,  2], its 
removal results in a highly complex transcriptional phe-
notype (Fig. 3b, c). As shown in Fig. 3b, female embryos 
showed more extensive dysregulation of gene expression 
than did male embryos, with many genes upregulated or 
downregulated.
Additional file  3: Table S2 shows differential 
gene  expression in male versus female Fbxl10 null 
mutants, and Fig.  3c shows examples of genes that 
showed sex-specific dysregulation. The imprinted 
Meg3 and Gtl2 genes [15] were notably upregulated in 
mutant XX embryos relative to XY embryos, although 
other nearby genes such as Rian were expressed at 
normal levels (Fig. 3c). Expression of Meg3 and Gtl2 was 
increased by a factor of greater than 2, which suggests 
that activation of the normally silent imprinted alleles 
was unlikely to be responsible for the increased expres-
sion. Abnormalities of gene expression were widespread 
and more apparent in female than in male embryos.
Abnormal expression of X‑linked genes in the absence 
of FBXL10
RNA transcripts derived from X-linked genes were iden-
tified in RNA-seq data and the extent of dysregulation 
compared to that of autosomal genes in male and female 
Fbxl10-null embryos. As shown in Fig. 4a, c, a highly sig-
nificant dysregulation of X-linked genes was apparent in 
female but not male embryos, with an overall net reduc-
tion of expression. This is apparent in the histogram of 
Fig.  4b, where autosomal genes can be seen to be also 
dysregulated to a much greater extent in female than in 
male embryos. Overall abnormalities of gene expression 
were much greater in female embryos, and dysregulation 
of X-linked genes (with the exception of Tsix; see below) 
was apparent only in female embryos. Quantitative RT-
PCR confirmed the female-specific downregulation of 
ten X-linked genes (Additional file 1: Fig. S3).
Normal reactivation of the paternally imprinted X 
chromosome in Fbxl10 null mutants
The observed global downregulation of the active X chro-
mosome could arise from the failure of the paternally 
imprinted X chromosome to be reactivated. A defec-
tive counting in cells that have a paternally imprinted X 
Fig. 2 Sexually dimorphic anatomical phenotypes in Fbxl10T/T embryos. Embryos were collected at E10.5 and sexes determined by the presence or 
absence of the Sry gene. The most severely affected male embryos resembled the least severely affected female embryos
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chromosome would cause the inactivation of two X chro-
mosomes in half the cells (the cells that randomly inacti-
vate the X chromosome of maternal origin). We reasoned 
that a failure to reactivate the paternally imprinted X 
chromosome would lead to a skewed X inactivation pat-
tern. We tested for potential allelic imbalance of two 
X-linked transcripts using single nucleotide polymor-
phisms (SNPs) to trace the parental origin of the tran-
scripts (Additional file  1: Fig. S4). Haus7 and Sh3bgr1 
are X-linked genes with reduced expression in mutant 
females (Additional file 1: Fig. S4a, c). Our SNP analysis 
showed that transcripts from each parental allele were 
equally represented in female mutant embryos (Addi-
tional file 1: Fig. S4b, d). Therefore, X inactivation is not 
skewed in female embryos that lack FBXL10, which indi-
cates that choice in somatic X inactivation is normal in 
the absence of FBXL10.
Abnormal expression of Xist RNA and Xist RNA‑binding 
factors in Fbxl10‑null female embryos
The Xist gene was found to be greatly upregulated in 
Fbxl10 female mutant embryos, while the male-specific 
Tsix gene was downregulated in mutant male embryos 
(Fig.  5). Xist expression was increased by considerably 
more than twofold. Furthermore, no Xist transcripts 
were detectable in mutant male embryos, which indicates 
that removal of FBXL10 did not directly activate Xist 
expression.
A set of 81 proteins has recently been reported to bind 
to Xist RNA specifically in female cells that have under-
gone X inactivation [14]. Two of these Xist-associated 
proteins (RING1B/RNF2 and RYBP) have been reported 
to physically interact with FBXL10 [1,  6, 14]. We used 
statistically rigorous gene set enrichment analysis (GSEA; 
[13]) to evaluate the relative levels of the mRNAs that 
encode these 81 factors in mutant female versus mutant 
male embryos; the results are shown in Fig.  6. Pro-
nounced sex-specific reductions in most of these factors 
were observed, together with a strong overexpression of 
Xist (Fig. 6b). Chu et al. [14] identified the factors WTAP, 
RING1B/RNF2, HNRNPK, and HNRNPU as directly 
involved in Xist-mediated X inactivation, and all of these 
factors were markedly downregulated in female but not 
male Fbxl10-null embryos (Fig. 6a).
Discussion
Individual ablations of FBXL10-1 and FBXL-2 produced 
non-overlapping phenotypes. The long form deletion 
produced low-penetrance exencephaly, colobomo, and 
rare tail kinks with low mortality [10], while deletion of 
the short form caused high-penetrance anterior–pos-
terior craniofacial contraction with strain-dependent 
cleft palate and an eyes-open-at-birth phenotype, with 
high perinatal lethality. This is an unusual case in which 
selective deletion of two isoforms of the same gene 
gives rise to highly dissimilar phenotypes. The data also 
Fig. 3 Sex-specific gene dysregulation in Fbxl10T/T embryos. a Representative littermate embryos dissected at embryonic day 9.5. Males and 
females are indistinguishable on the basis of their morphology at this stage of development. b Greater variation in gene expression in female 
mutant embryos as determined by RNA-seq. c Examples of sex-specific expression abnormalities in Fbxl10T/T embryos. The Ddit4, Vegfa, and Stc2 
genes, and the imprinted gene Meg3, are all markedly overexpressed in female Fbxl10T/T embryos
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indicate that histone demethylation via the JmjC domain 
of FBXL10-1 is largely dispensable for the biological 
activity of the protein. There are other cases in which the 
histone modifying domains of chromosomal proteins 
are largely dispensable; the histone demethylase activity 
of KDM6B is dispensable for the biological function of 
the protein [16], as is the E3 ubiquitin ligase activity of 
RING1B/RNF2 [17].
We observed sexual dimorphism in the form of more 
severe developmental defects in female mice that lacked 
FBXL10-2; we then tested for sexually dimorphic pheno-
types in mouse embryos that lacked both the FBXL10-1 
and FBXL10-2. The Fbxl0 null mutation was found to 
cause much more severe developmental abnormalities 
and earlier death in female embryos; at E10.5, the most 
advanced female embryos resembled the least advanced 
male embryos. Analysis of gene expression abnormali-
ties by RNA-seq on single E9.5 embryos showed much 
greater dysregulation of gene expression in female 
embryos. This was unexpected given that FBXL10 is 
Fig. 4 Dysregulation of X-linked genes in female but not male Fbxl10T/T embryos. a Transcripts from X-linked genes were computationally isolated 
from RNA-seq data and expression levels compared to E9.5 Fbxl10T/T versus Fbxl10+/+ embryos. b Histogram analysis of the RNA-seq data in a. Both 
autosomal and X-linked genes are dysregulated in female Fbxl10T/T embryos, but X-linked genes are more severely affected and a greater extent of 
downregulation is apparent. c Downregulation of X-linked genes in female Fbxl10T/T embryos is of high statistical significance
Fig. 5 Overexpression of Xist RNA in female Fbxl10T/T embryos (upper 
two rows); underexpression of Tsix and lack of activation of Xist in 
male Fbxl10T/T embryos (lower two rows)
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Fig. 6 a Underexpression in Fbxl10T/T female embryos of selected genes that encode factors reported to interact with Xist RNA [14]. b Expression of 
genes that encode Xist RNA-binding factors in female Fbxl10T/T embryos (bottom); normal expression of the same genes in male Fbxl10T/T embryos 
(top). Analysis was performed via GSEA [13]. These data indicate that the overexpression of Xist RNA as shown in Fig. 5 is concomitant with reduced 
levels of proteins that associate with Xist RNA
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localized to nearly all CpG-rich promoters [1, 3], which 
account for ~76 % of all promoters.
The sexually dimorphic phenotypes were apparent 
well prior to the onset of sexual differentiation, which 
suggested that abnormalities of sex chromosome func-
tion might be involved. Inspection of RNA-seq data 
showed that Xist was markedly overexpressed in Fbxl10 
null mutant female embryos, while Tsix was reduced 
in mutant male embryos. Deficiencies of the MYST1-
(MOF)-containing MSL and NSL complexes have been 
reported to cause downregulation of Tsix and biallelic 
expression of Xist with Xist RNA coating of both X chro-
mosomes [18], but examination of RNA-seq data showed 
that all of the ~20 components of the MSL and NSL 
complexes were expressed normally in male and female 
Fbxl10 mutants (data not shown). Deletion of Tsix has 
also been reported to cause biallelic expression of Xist in 
female cells [19], but the marked downregulation of Tsix 
in male Fbxl10 mutant embryos or ES cells did not result 
in detectable expression of Xist from the male X chromo-
some, and expression of Tsix was not detectable in mutant 
female embryos. Furthermore, FBXL10 is not detectably 
enriched at the promoters of the Xist or Tsix genes [1].
A recent study identified a set of ~81 proteins that 
interact with Xist RNA [14]. We found that many of 
these factors were expressed at reduced levels in Fbxl10-
null female embryos but were expressed at normal levels 
in mutant male embryos. Hnrnpu, which is required for 
the association of the Xist complex with the inactive X 
chromosome [20], is reduced by more than twofold, as is 
the histone ubiquitin transferase RING1B/RNF2. The pro-
nounced imbalance created by excess Xist RNA combined 
to the reduced concentrations of Xist binding factors will 
create a state in which highly heterogeneous and ectopic 
Xist–protein complexes in abnormally large amounts can 
disrupt patterns of gene expression. Genes on the X chro-
mosome encode numerous transcription regulators; these 
include Tbx22, Dax1, Sox3, and Pou3F4. We suggest that 
ectopic Xist silencing complexes that result from the over-
expression of Xist coupled to the underexpression of Xist 
binding factors leads to a pervasive dysregulation of gene 
expression driven by repression of genes on the active X 
chromosome. This gene dysregulation is independent of 
the methylation abnormalities induced by the deprivation 
of FBXL10, which affects only genes that are bound by 
Polycomb Repressive Complexes 1 and 2 [9].
We propose a model under which ectopic and het-
erogeneous Xist-containing silencing complexes are 
assembled as a result of the overexpression of Xist and 
underexpression of Xist binding factors after ablation of 
FBXL10. Under this model the ectopic, abundant, and 
abnormal Xist-containing silencing complexes saturate 
the inactive X chromosome and spill over to silence genes 
on the active X chromosome and possibly on autosomes 
after X inactivation (Fig. 7).
Conclusions
We show that removal of FBXL10 results in overexpres-
sion of Xist in females, reduced expression of proteins 
reported to complex with Xist RNA, and greater pertur-
bations of global gene expression profiles in females as 
compared to males; the data indicate that FBXL10 is a 
factor required for the coordinated expression of Xist, 
Tsix, and Xist RNA-associated factors. In the absence of 
FBXL10 abnormal X inactivation leads to a global reduc-
tion of X-linked gene expression and dysregulated expres-
sion of autosomal genes specifically in female embryos.
Additional files
Additional file 1: Figure S1. Description of targeting strategy used to 
generate the Fbxl10∆−2/∆−2 allele, selectively deleted for Fbxl10-2 without 
effect on Fbxl10-1. Figure S2. Cranial defects in Fbxl10∆−2/∆−2 mutants. 
Figure S3. Female-specific downregulation of 10 selected X-linked genes 
as determined by quantitative RT-PCR. Figure S4. Normal allelic expres-
sion of X-linked genes indicating that downregulation of the active X 
chromosome is independent of its parental origin.
Additional file 2: Table S1. Female-specific mortality of Fbxl10∆−2/∆−2 
mutants. Observed frequencies of indicated genotype in males and 
females at birth and at 21 days after birth.
Additional file 3: Table S2. RefSeq genes with abnormal expression in 
females and males Fbxl10T/T E9.5 embryos as compared to wild type.
Fig. 7 Proposed mechanism of Xist-mediated female-specific gene 
dysregulation in Fbxl10T/T embryos. Under this model the overex-
pression of Xist RNA and the underexpression of proteins that bind 
to Xist RNA results in the formation of increased levels of aberrant 
Xist RNA–protein complexes that are heterogeneous and which 
induce neomorphic gene dysregulation, primarily in females and 
largely affecting X-linked genes. Dysregulation of autosomal genes 
in female embryos could result from the direct effects of mistargeted 
abnormal Xist complexes or from the downregulation of transcription 
factor genes on the active X chromosome by abnormal Xist–protein 
complexes
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